-
1
The HALP score combines hemoglobin, albumin, lymphocyte, and platelet levels, indicating nutritional and inflammatory conditions.
-
2
A meta-analysis of ten cohort studies with 1,953 patients assessed the relationship between HALP scores and survival outcomes in esophageal cancer.
-
3
Patients with low HALP scores showed significantly inferior overall survival compared to those with high HALP scores (HR: 1.74, 95% CI: 1.53-1.98).
-
4
Low HALP scores were also associated with diminished progression-free survival in five studies (HR: 1.82, 95% CI: 1.40-2.37).
-
5
The findings suggest that reduced baseline HALP scores correlate with poorer overall and progression-free survival in esophageal and gastro-esophageal junction cancer.
